Wukun Liu

4.0k total citations · 2 hit papers
75 papers, 3.2k citations indexed

About

Wukun Liu is a scholar working on Organic Chemistry, Oncology and Molecular Biology. According to data from OpenAlex, Wukun Liu has authored 75 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Organic Chemistry, 35 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Wukun Liu's work include Metal complexes synthesis and properties (24 papers), N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (12 papers) and Synthesis and Biological Evaluation (12 papers). Wukun Liu is often cited by papers focused on Metal complexes synthesis and properties (24 papers), N-Heterocyclic Carbenes in Organic and Inorganic Chemistry (12 papers) and Synthesis and Biological Evaluation (12 papers). Wukun Liu collaborates with scholars based in China, Germany and Austria. Wukun Liu's co-authors include Ronald Gust, Yunlong Lu, Mianli Bian, Zhibin Yang, Rong Fan, Ulrich Abram, Adelheid Hagenbach, Zhongren Xu, Kerstin Bensdorf and Maria T. Proetto and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and Angewandte Chemie International Edition.

In The Last Decade

Wukun Liu

71 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs

2012 668 citations Wukun Liu, Ronald Gust Chemical Society Reviews profile →
Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases

2022 179 citations Yunlong Lu, Xiaoyan Ma et al. Chemical Society Reviews profile →

Peers

Wukun Liu

ONCOL

Alessio Terenzi Italy

Elena Cerrada Spain

Albert Isidro‐Llobet United Kingdom

Yun‐Jun Liu China

Hai‐Bing Zhou China

Goran N. Kaluđerović Germany

Shaohua Gou China

Elisabetta Gabano Italy

Yu Rao China

Allan M. Jordan United Kingdom

Alessio Terenzi Italy

Wukun Liu

1.4k ×0.7

1.2k ×1.0

ONCOL

1.3k ×1.8

372 ×1.4

401 ×1.6

Citations per year, relative to Wukun Liu Wukun Liu (= 1×) peers Alessio Terenzi

Countries citing papers authored by Wukun Liu

Since Specialization

Citations

This map shows the geographic impact of Wukun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wukun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wukun Liu more than expected).

Fields of papers citing papers by Wukun Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wukun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wukun Liu. The network helps show where Wukun Liu may publish in the future.

Co-authorship network of co-authors of Wukun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Wukun Liu. A scholar is included among the top collaborators of Wukun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wukun Liu. Wukun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Qiuyue, et al.. (2025). A dinuclear gold(I) complex with bis(N-heterocyclic carbene) ligands potentiated immune responses against liver cancer via ROS-driven endoplasmic reticulum stress and ferroptosis. Chinese Chemical Letters. 36(12). 110940–110940. 3 indexed citations

Wang, Lingling, Xiaoyan Ma, Ling Zhou, et al.. (2025). Dual-Targeting TrxR-EGFR Alkynyl-Au(I) Gefitinib Complex Induces Ferroptosis in Gefitinib-Resistant Lung Cancer via Degradation of GPX4. Journal of Medicinal Chemistry. 68(5). 5275–5291. 5 indexed citations

Wang, Meiyu, Qiong Chen, Mengshi Wang, et al.. (2025). Glabridin‐Gold(I) Complex as a Novel Immunomodulatory Agent Targeting TrxR and MAPK Pathways for Synergistic Enhancement of Antitumor Immunity. Advanced Science. 12(41). e04729–e04729. 1 indexed citations

Xia, Siyu, Weihui Zhong, Zhongren Xu, et al.. (2025). Au–Mn Bond Formal Metathesis with Ar–F via Synergistic Bimetallic Activation. Journal of the American Chemical Society. 147(41). 37779–37787.

Chen, Xiuli, Lin Lv, Jianqiang Xu, et al.. (2025). Au(III) Schiff base complexes as oxidoreductase inhibitors against carbapenem- and colistin-resistant Gram-negative bacteria via targeting redox active motifs. Redox Biology. 86. 103800–103800.

Wang, Yawen, Xiaoyan Ma, Xuejie Chen, et al.. (2024). Gold(I) complexes bearing EGFR-inhibiting ligands as anti-HCC agents through dual targeting of EGFR and TrxR. European Journal of Medicinal Chemistry. 283. 117137–117137. 3 indexed citations

Wang, Meiyu, et al.. (2024). Synthesis, characterization and anti-ovarian cancer activities of novel biphenyl-NHC-gold(I) complexes. Journal of Organometallic Chemistry. 1013. 123167–123167. 2 indexed citations

Ma, Xiaoyan, et al.. (2024). Erlotinib-Gold(I) Complex Induces Leukemia Cell DC Differentiation and Remodels the Immunosuppressive Microenvironment. Journal of Medicinal Chemistry. 67(24). 21795–21810. 2 indexed citations

Ma, Xiaoyan, et al.. (2024). Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents. Medicinal Research Reviews. 44(4). 1545–1565. 7 indexed citations

10.

Wen, Zhenfan, Zhibin Yang, Dahong Chen, et al.. (2024). Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by Liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 67(3). 1982–2003. 32 indexed citations

11.

Xu, Zhongren, et al.. (2024). Recent Advances of Metal Complexes in the Treatment of Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 68(1). 1–17. 5 indexed citations

12.

Yang, Zhibin, Mianli Bian, Lin Lv, et al.. (2023). Tumor-Targeting NHC–Au(I) Complex Induces Immunogenic Cell Death in Hepatocellular Carcinoma. Journal of Medicinal Chemistry. 66(6). 3934–3952. 45 indexed citations

13.

Liu, Lijuan, et al.. (2023). Research Progress on Bioactive Metal Complexes against ER-Positive Advanced Breast Cancer. Journal of Medicinal Chemistry. 66(4). 2235–2256. 14 indexed citations

14.

Lu, Yunlong, Yuan‐Hao Liu, Xiaoyan Ma, et al.. (2023). NHC-gold(I)-alkyne complexes induced hepatocellular carcinoma cell death through bioorthogonal activation by palladium complex in living system. Chinese Chemical Letters. 34(9). 108413–108413. 17 indexed citations

15.

Xu, Zhongren, Qiuyue Lu, Min Shan, et al.. (2023). NSAID–Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer. Journal of Medicinal Chemistry. 66(12). 7813–7833. 24 indexed citations

16.

Lu, Yunlong, Xiaoyan Ma, Lin Lv, et al.. (2022). Recent development of gold(i) and gold(iii) complexes as therapeutic agents for cancer diseases. Chemical Society Reviews. 51(13). 5518–5556. 179 indexed citations breakdown →

17.

Xu, Zhongren, Jianqiang Xu, Shibo Sun, et al.. (2022). Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma. Redox Biology. 54. 102351–102351. 91 indexed citations

18.

Bian, Mianli, Ying Sun, Yuan‐Hao Liu, et al.. (2020). A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti‐Ovarian‐Cancer Agent by Inhibiting TrxR and Activating ROS‐Mediated ERS. Chemistry - A European Journal. 26(31). 7092–7108. 56 indexed citations

19.

Li, Yingjun, Kalyan Kumar Pasunooti, Hanjing Peng, et al.. (2020). Design and Synthesis of Tetrazole- and Pyridine-Containing Itraconazole Analogs as Potent Angiogenesis Inhibitors. ACS Medicinal Chemistry Letters. 11(6). 1111–1117. 4 indexed citations

20.

Lu, Yunlong & Wukun Liu. (2020). Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer. Journal of Medicinal Chemistry. 63(24). 15094–15114. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact